Figure 1.
Schematic overview of the steps involved in adaptive immunity as provided by CRISPR–Cas. (A) Adaptation stage, featuring the introduction of viral DNA/RNA (curved gray line) with protospacer 1 (dark blue) and an adjacent PAM (red). Protospacer 1 is incorporated in the bacterial genome as spacer 1 (dark blue) flanked by two repeats (orange) in the CRISPR array alongside spacer 2 (green). (B) Expression stage, wherein a Cas protein (light blue) is produced and pre-crRNA is transcribed and processed into mature crRNAs, which subsequently form functional RNP complexes with the Cas protein. (C) Interference stage, where a second infection is targeted for degradation by crRNA-guided Cas proteins, binding to matching protospacers adjacent to PAMs.
CRISPR–Cas adaptive immunity.

Schematic overview of the steps involved in adaptive immunity as provided by CRISPR–Cas. (A) Adaptation stage, featuring the introduction of viral DNA/RNA (curved gray line) with protospacer 1 (dark blue) and an adjacent PAM (red). Protospacer 1 is incorporated in the bacterial genome as spacer 1 (dark blue) flanked by two repeats (orange) in the CRISPR array alongside spacer 2 (green). (B) Expression stage, wherein a Cas protein (light blue) is produced and pre-crRNA is transcribed and processed into mature crRNAs, which subsequently form functional RNP complexes with the Cas protein. (C) Interference stage, where a second infection is targeted for degradation by crRNA-guided Cas proteins, binding to matching protospacers adjacent to PAMs.

Close Modal

or Create an Account

Close Modal
Close Modal